These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29441403)

  • 1. Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.
    Kozu K; Sugimura K; Aoki T; Tatebe S; Yamamoto S; Yaoita N; Shimizu T; Nochioka K; Sato H; Konno R; Satoh K; Miyata S; Shimokawa H
    Heart Vessels; 2018 Aug; 33(8):939-947. PubMed ID: 29441403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the Need for Upfront Combination Therapy in Pulmonary Arterial Hypertension.
    Bajwa AA; Qureshi T; Shujaat A; Seeram V; Jones LM; Al-Saffar F; Cury JD
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):395-400. PubMed ID: 25613465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
    Kylhammar D; Persson L; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies.
    Zijlstra WMH; Douwes JM; Rosenzweig EB; Schokker S; Krishnan U; Roofthooft MTR; Miller-Reed K; Hillege HL; Ivy DD; Berger RMF
    J Am Coll Cardiol; 2014 May; 63(20):2159-2169. PubMed ID: 24681143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis].
    Volkov AV; Kurmukov IA; Yudkina NN; Glukhova SI; Nikolaeva EV
    Ter Arkh; 2015; 87(1):49-56. PubMed ID: 25823269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
    Galiè N; Jansa P; Pulido T; Channick RN; Delcroix M; Ghofrani HA; Le Brun FO; Mehta S; Perchenet L; Rubin LJ; Sastry BKS; Simonneau G; Sitbon O; Souza R; Torbicki A
    Eur Heart J; 2017 Apr; 38(15):1147-1155. PubMed ID: 28329315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C
    Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular Diastolic Pressure Ratio as a Marker of Treatment Response in Pulmonary Hypertension.
    Jose A; King CS; Shlobin OA; Kiernan JM; Cossa NA; Brown AW; Nathan SD
    Chest; 2017 Nov; 152(5):980-989. PubMed ID: 28527879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of rapid sequential combination therapy on distinct haemodynamic measures in newly diagnosed pulmonary arterial hypertension.
    Kramer T; Nattmann P; Gerhardt F; Stafiej P; Dumitrescu D; Ten Freyhaus H; Wißmüller M; Hohmann C; Baldus S; Rosenkranz S
    ESC Heart Fail; 2024 Jun; 11(3):1540-1552. PubMed ID: 38224960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study.
    Hascoet S; Fournier E; Jaïs X; Le Gloan L; Dauphin C; Houeijeh A; Godart F; Iriart X; Richard A; Radojevic J; Amedro P; Bosser G; Souletie N; Bernard Y; Moceri P; Bouvaist H; Mauran P; Barre E; Basquin A; Karsenty C; Bonnet D; Iserin L; Sitbon O; Petit J; Fadel E; Humbert M; Ladouceur M
    Arch Cardiovasc Dis; 2017 May; 110(5):303-316. PubMed ID: 28286190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long term anti-inflammatory effects of bosentan therapy in patients with pulmonary arterial hypertension: relation to clinical and hemodynamic responses.
    Karavolias GK; Georgiadou P; Gkouziouta A; Kariofillis P; Karabela G; Tsiapras D; Sbarouni E; Chaidaroglou A; Degiannis D; Adamopoulos S; Voudris V
    Expert Opin Ther Targets; 2010 Dec; 14(12):1283-9. PubMed ID: 20958219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension.
    Klinger JR; Oudiz RJ; Spence R; Despain D; Dufton C
    Am J Cardiol; 2011 Jul; 108(2):302-7. PubMed ID: 21545989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between peripheral venous oxygen saturation and hemodynamic parameters in patients with pulmonary hypertension].
    Hong C; Li JY; Chen RK; Liu CL; Wang XN; Qing SM; Su XF; Zhang NF
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Jan; 41(1):37-40. PubMed ID: 29343014
    [No Abstract]   [Full Text] [Related]  

  • 18. Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation.
    Hefke T; Zittermann A; Fuchs U; Schulte-Eistrup S; Gummert JF; Schulz U
    Thorac Cardiovasc Surg; 2012 Feb; 60(1):26-34. PubMed ID: 21432755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.
    Mazimba S; Welch TS; Mwansa H; Breathett KK; Kennedy JLW; Mihalek AD; Harding WC; Mysore MM; Zhuo DX; Bilchick KC
    Heart Lung Circ; 2019 May; 28(5):752-760. PubMed ID: 29748060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension.
    Jacobs W; van de Veerdonk MC; Trip P; de Man F; Heymans MW; Marcus JT; Kawut SM; Bogaard HJ; Boonstra A; Vonk Noordegraaf A
    Chest; 2014 Jun; 145(6):1230-1236. PubMed ID: 24306900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.